Detailed answers about KOREESA MEDICAL SOLUTIONS LABORATORY CO., LTD, including incorporation, status, business activity, and accounts information.
When was KOREESA MEDICAL SOLUTIONS LABORATORY CO., LTD founded?
KOREESA MEDICAL SOLUTIONS LABORATORY CO., LTD was officially incorporated on 7 December 2020 and is registered under company number 13067703. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is KOREESA MEDICAL SOLUTIONS LABORATORY CO., LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of KOREESA MEDICAL SOLUTIONS LABORATORY CO., LTD?
KOREESA MEDICAL SOLUTIONS LABORATORY CO., LTD's current status is Active - Proposal to Strike off. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does KOREESA MEDICAL SOLUTIONS LABORATORY CO., LTD do?
KOREESA MEDICAL SOLUTIONS LABORATORY CO., LTD operates in the following sector: 99999 - Dormant Company. This provides insight into the company's primary business activity and industry focus.
What is KOREESA MEDICAL SOLUTIONS LABORATORY CO., LTD's registered address?
The registered office address of KOREESA MEDICAL SOLUTIONS LABORATORY CO., LTD is 4D SALISBURY ROAD, WESTON-SUPER-MARE, SOMERSET, UNITED KINGDOM, BS22 8EW. This is the official address filed with Companies House for legal and statutory correspondence.
Is KOREESA MEDICAL SOLUTIONS LABORATORY CO., LTD financially stable?
The most recent accounts for KOREESA MEDICAL SOLUTIONS LABORATORY CO., LTD were made up to 31 December 2023, filed as DORMANT. Next accounts are due by 30 September 2025.